UniProtKB/Swiss-Prot Q7Z6M1: Variant p.His73Tyr

Rab9 effector protein with kelch motifs
Gene: RABEPK
Feedback?

Variant information Variant position:

73 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Histidine (H) to Tyrosine (Y) at position 73 (H73Y, p.His73Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (H) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1128362 [ dbSNP | Ensembl ]

Sequence information Variant position:

73 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

372 The length of the canonical sequence.
Location on the sequence:

VGGANPNRSFSDVHTMDLGK H QWDLDTCKGLLPRYEHASFI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VGGANPNRSFSDVHTMDLGKHQWDLDTCKGLLPRYEHASFI

Mouse                         VGGANPNQSFSDVHTMDLGTHQWDTATREGLLPRYEHASFL

Rat                           VGGANPNQSFSDVHTMDLGTHRWDTATREGLLPRYEHASFL

Bovine                        VGGADPNRSFSDVHTIDLGTHQWDLATSEGLLPRYEHTSFI

Chicken                       LGGADPAGAFADAHFVELGAHLWAPAAWSGLRPRYEHATFL

Xenopus laevis                LGGADPSGCYSDTHIIDLDNHEWDNPDSEGLLPRYEHASFI

Zebrafish                     VGGANPSGSFADSYIINLDTHQWDLPDWEGLQARYEHCSFT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 372	Rab9 effector protein with kelch motifs
Repeat	49 – 95	Kelch 1
Alternative sequence	71 – 121	Missing. In isoform 2.

Literature citations
Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).
Halleck A.; Ebert L.; Mkoundinya M.; Schick M.; Eisenstein S.; Neubert P.; Kstrang K.; Schatten R.; Shen B.; Henze S.; Mar W.; Korn B.; Zuo D.; Hu Y.; LaBaer J.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT TYR-73; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2); VARIANTS GLY-60; TYR-73 AND GLY-313;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.